Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1766823

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1766823

United Kingdom Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 9990
PDF (Global License)
USD 14985

Add to Cart

GlobalData's "United Kingdom Oncology Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United Kingdom Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The United Kingdom Oncology Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Oncology is segmented as follows -

  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests

Reasons to Buy

The United Kingdom Oncology Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME25626CCDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Oncology Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Oncology Market, United Kingdom

  • 3.1 Oncology Market, United Kingdom, Revenue ($m), 2018-2033
    • 3.1.1 ALK Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 3.1.2 BCR-ABL Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 3.1.3 BRAF Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 3.1.4 BRCA Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 3.1.5 Colorectal Cancer Screening Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 3.1.6 EGFR Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 3.1.7 HER2 Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 3.1.8 KRAS Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
  • 3.2 Oncology Market, United Kingdom, Volume (Units), 2018-2033
    • 3.2.1 ALK Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 3.2.2 BCR-ABL Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 3.2.3 BRAF Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 3.2.4 BRCA Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 3.2.5 Colorectal Cancer Screening Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 3.2.6 EGFR Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 3.2.7 HER2 Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 3.2.8 KRAS Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
  • 3.3 Oncology Market, United Kingdom, Average Price ($) , 2018-2033
  • 3.4 Oncology Market, United Kingdom, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in United Kingdom, Oncology Market

5 Oncology Market Pipeline Products

6 Financial Deals Landscape

7 Recent Developments

8 Appendix

Product Code: GDME25626CCDB

List of Table

List of Tables

  • Table 1: Oncology Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 2: ALK Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 3: BCR-ABL Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 4: BRAF Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 5: BRCA Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 6: Colorectal Cancer Screening Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 7: EGFR Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 8: HER2 Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 9: KRAS Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 10: Oncology Market, United Kingdom, Volume (Units), 2018-2033
  • Table 11: ALK Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 12: BCR-ABL Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 13: BRAF Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 14: BRCA Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 15: Colorectal Cancer Screening Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 16: EGFR Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 17: HER2 Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 18: KRAS Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Table 19: Oncology Market, United Kingdom, Average Price ($), 2018-2033
  • Table 20: Oncology Market, United Kingdom, Company Share by Revenue ($m), 2024
  • Table 21: Oncology Market Pipeline Products
  • Table 22: EDX Medical Enters into Distribution Agreement with miRdetect
  • Table 23: Owkin Enters into Co-Development Agreement with AstraZeneca
  • Table 24: A. Menarini Diagnostics Enters into Distribution Agreement with Nucleix
  • Table 25: Vidac Pharma Holding Raises Approximately USD0.64 Million in Venture Financing
  • Table 26: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figure

List of Figures

  • Figure 1: Oncology Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: ALK Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: BCR-ABL Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 4: BRAF Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 5: BRCA Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 6: Colorectal Cancer Screening Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: EGFR Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: HER2 Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 9: KRAS Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 10: Oncology Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 11: ALK Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 12: BCR-ABL Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 13: BRAF Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 14: BRCA Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 15: Colorectal Cancer Screening Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 16: EGFR Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 17: HER2 Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 18: KRAS Tests Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 19: Oncology Market, United Kingdom, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!